Back to Search Start Over

A phase III study of doxorubicin (A) versus cisplatin (P)/interferon alpha-2b (I)/doxorubicin (A)/fluorouracil (F) combination chemotherapy (PIAF) for inoperable hepatocellular carcinoma (HCC)

Authors :
Winnie Yeo
Zee, B.
Leung, W. T.
Lau, W. Y.
Mok, T. S. K.
Wong, H. T. M.
Koh, J.
Yu, S.
Chan, A. T. C.
Johnson, P. J.
Source :
ResearcherID

Details

Database :
OpenAIRE
Journal :
ResearcherID
Accession number :
edsair.dedup.wf.001..13a38015d72ad28b2b6f2ccbdec63952

Tools

Authors Abstract Subjects Details